Karalius Vytas P, Rucinski Stefanea L, Mandrekar Jayawant N, Patel Robin
Mayo Clinic School of Medicine Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Laboratory Medicine and Pathology Division of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, MN.
Medicine (Baltimore). 2017 May;96(20):e6730. doi: 10.1097/MD.0000000000006730.
Whooping cough is traditionally ascribed to Bordetella pertussis; however, Bordetella parapertussis can cause a similar clinical syndrome. This study describes an outbreak of B. parapertussis in Southeastern Minnesota and the United States (US) in 2014. This was a retrospective analysis of Mayo Clinic and Mayo Medical Laboratories patients who tested positive for B. parapertussis from 2012 to 2014. The medical records of Mayo Clinic patients who tested positive in 2014 were reviewed for demographic information, presenting symptoms, disease course, and vaccination history. In Southeast Minnesota, 81% of the 31 patients who tested positive for B. parapertussis in 2014 were found to be positive from October through December. Their mean age was 5.9 years. Five reported "exposure to pertussis." Two pairs of siblings were affected. Patients reported having had symptoms for an average of 2.6 weeks before nasopharyngeal specimen collection for B. parapertussis testing. Cough was the primary symptom reported. Forty percent reported posttussive vomiting, 40% coryza, 32% apnea/sleep disturbance, and 12% sore throat. All were current with pertussis vaccination. Based on the review of national data, an outbreak occurred nationally in the Northeast and Midwest US over the same time period. In 2014, there was an outbreak of B. parapertussis in Southeastern Minnesota and likely other parts of the US. The presenting illness was similar to that of B. pertussis. All patients were vaccinated against pertussis, suggesting that pertussis vaccination is ineffective against B. parapertussis.
百日咳传统上被认为是由百日咳博德特氏菌引起的;然而,副百日咳博德特氏菌也可导致类似的临床综合征。本研究描述了2014年美国明尼苏达州东南部副百日咳博德特氏菌的一次暴发。这是一项对2012年至2014年在梅奥诊所和梅奥医学实验室检测出副百日咳博德特氏菌呈阳性的患者进行的回顾性分析。对2014年检测呈阳性的梅奥诊所患者的病历进行了审查,以获取人口统计学信息、出现的症状、病程和疫苗接种史。在明尼苏达州东南部,2014年检测出副百日咳博德特氏菌呈阳性的31名患者中,81%在10月至12月期间呈阳性。他们的平均年龄为5.9岁。5人报告“接触过百日咳”。有两对兄弟姐妹受到影响。患者报告在采集用于副百日咳博德特氏菌检测的鼻咽标本前平均已有2.6周的症状。咳嗽是报告的主要症状。40%的患者报告有咳嗽后呕吐,40%有鼻卡他,32%有呼吸暂停/睡眠障碍,12%有咽痛。所有患者均按程序接种了百日咳疫苗。根据对全国数据的审查,同期在美国东北部和中西部地区全国范围内发生了一次暴发。2014年,美国明尼苏达州东南部以及可能美国其他地区出现了副百日咳博德特氏菌的一次暴发。出现的疾病与百日咳博德特氏菌引起的疾病相似。所有患者均接种了百日咳疫苗,这表明百日咳疫苗对副百日咳博德特氏菌无效。